[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Postmenopausal Vaginal Atrophy Treatment Market Analysis 2016-2020 and Forecast 2021-2026

February 2021 | 85 pages | ID: GFE4ABB8324EN
99Strategy

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SNAPSHOT

Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.

The global Postmenopausal Vaginal Atrophy Treatment market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Postmenopausal Vaginal Atrophy Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Creams
  • Tablets
  • Patches
  • Rings
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
  • Allergan
  • Pfizer
  • Shionogi
  • Novo Nordisk
  • Teva Pharmaceutical
  • Bayer.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Topical Estrogen
  • Systemic Estrogen
  • Non-hormonal Therapy
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW

1.1 Postmenopausal Vaginal Atrophy Treatment Industry
Figure Postmenopausal Vaginal Atrophy Treatment Industry Chain Structure
  1.1.1 Overview
  1.1.2 Development of Postmenopausal Vaginal Atrophy Treatment
1.2 Market Segment
  1.2.1 Upstream
Table Upstream Segment of Postmenopausal Vaginal Atrophy Treatment
  1.2.2 Downstream
Table Application Segment of Postmenopausal Vaginal Atrophy Treatment
Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2026, by Application, in USD Million
  1.2.3 COVID-19 Impact
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT MARKET BY TYPE

3.1 By Type
  3.1.1 Creams
Table Major Company List of Creams
  3.1.2 Tablets
Table Major Company List of Tablets
  3.1.3 Patches
Table Major Company List of Patches
  3.1.4 Rings
Table Major Company List of Rings
3.2 Market Size
Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2020, by Type, in USD Million
Figure Global Postmenopausal Vaginal Atrophy Treatment Market Growth 2016-2020, by Type, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2020, by Type, in Volume
Figure Global Postmenopausal Vaginal Atrophy Treatment Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Postmenopausal Vaginal Atrophy Treatment Market Forecast 2021-2026, by Type, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Market Forecast 2021-2026, by Type, in Volume

4 MAJOR COMPANIES LIST

4.1 Allergan (Company Profile, Sales Data etc.)
  4.1.1 Allergan Profile
Table Allergan Overview List
  4.1.2 Allergan Products & Services
  4.1.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Pfizer (Company Profile, Sales Data etc.)
  4.2.1 Pfizer Profile
Table Pfizer Overview List
  4.2.2 Pfizer Products & Services
  4.2.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Shionogi (Company Profile, Sales Data etc.)
  4.3.1 Shionogi Profile
Table Shionogi Overview List
  4.3.2 Shionogi Products & Services
  4.3.3 Shionogi Business Operation Conditions
Table Business Operation of Shionogi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Novo Nordisk (Company Profile, Sales Data etc.)
  4.4.1 Novo Nordisk Profile
Table Novo Nordisk Overview List
  4.4.2 Novo Nordisk Products & Services
  4.4.3 Novo Nordisk Business Operation Conditions
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Teva Pharmaceutical (Company Profile, Sales Data etc.)
  4.5.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
  4.5.2 Teva Pharmaceutical Products & Services
  4.5.3 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Bayer. (Company Profile, Sales Data etc.)
  4.6.1 Bayer. Profile
Table Bayer. Overview List
  4.6.2 Bayer. Products & Services
  4.6.3 Bayer. Business Operation Conditions
Table Business Operation of Bayer. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 MARKET COMPETITION

5.1 Company Competition
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue 2016-2020, by Company, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue Share in 2020, by Company, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Volume 2016-2020, by Company, in Volume
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Postmenopausal Vaginal Atrophy Treatment Market Concentration, in 2020
Figure Europe Postmenopausal Vaginal Atrophy Treatment Market Market Concentration, in 2020
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment MMarket Concentration, in 2020
Figure South America Postmenopausal Vaginal Atrophy Treatment Market Concentration, in 2020
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Concentration, in 2020

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Topical Estrogen
Figure Postmenopausal Vaginal Atrophy Treatment Demand in Topical Estrogen, 2016-2020, in USD Million
Figure Postmenopausal Vaginal Atrophy Treatment Demand in Topical Estrogen, 2016-2020, in Volume
  6.1.2 Demand in Systemic Estrogen
Figure Postmenopausal Vaginal Atrophy Treatment Demand in Systemic Estrogen, 2016-2020, in USD Million
Figure Postmenopausal Vaginal Atrophy Treatment Demand in Systemic Estrogen, 2016-2020, in Volume
  6.1.3 Demand in Non-hormonal Therapy
Figure Postmenopausal Vaginal Atrophy Treatment Demand in Non-hormonal Therapy, 2016-2020, in USD Million
Figure Postmenopausal Vaginal Atrophy Treatment Demand in Non-hormonal Therapy, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Postmenopausal Vaginal Atrophy Treatment Demand Forecast 2021-2026, by Application, in USD Million
Figure Postmenopausal Vaginal Atrophy Treatment Market Growth 2021-2026, by Application, in USD Million
Figure Postmenopausal Vaginal Atrophy Treatment Market Share in 2026, by Application, in USD Million
Table Postmenopausal Vaginal Atrophy Treatment Demand Forecast 2021-2026, by Application, in Volume
Table Postmenopausal Vaginal Atrophy Treatment Market Growth 2021-2026, by Application, in Volume
Table Postmenopausal Vaginal Atrophy Treatment Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand

7 REGION OPERATION

7.1 Regional Production
Table Postmenopausal Vaginal Atrophy Treatment Production 2016-2020, by Region, in USD Million
Table Postmenopausal Vaginal Atrophy Treatment Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2020, by Region, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Market Share 2016-2020, by Region, in USD Million
Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2020, by Region, in Volume
Table Global Postmenopausal Vaginal Atrophy Treatment Market Share 2016-2020, by Region, in Volume
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
Figure North America Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
Figure North America Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
Table North America Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
  7.3.2 Europe
    7.3.2.1 Overview
Figure Europe Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
Figure Europe Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
Table Europe Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
  7.3.4 South America
    7.3.4.1 Overview
Figure South America Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
Figure South America Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
Table South America Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Postmenopausal Vaginal Atrophy Treatment Market Forecast 2021-2026, by Region, in USD Million
Table Postmenopausal Vaginal Atrophy Treatment Market Forecast 2021-2026, by Region, in Volume

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
Table Price Factors List
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview

9 RESEARCH CONCLUSION
LIST OF TABLES
1. Table Upstream Segment of Postmenopausal Vaginal Atrophy Treatment
2. Table Application Segment of Postmenopausal Vaginal Atrophy Treatment
3. Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Tablets
5. Table Major Company List of Patches
6. Table Major Company List of Rings
7. Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2020, by Type, in USD Million
8. Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2020, by Type, in Volume
9. Table Global Postmenopausal Vaginal Atrophy Treatment Market Forecast 2021-2026, by Type, in USD Million
10. Table Global Postmenopausal Vaginal Atrophy Treatment Market Forecast 2021-2026, by Type, in Volume
11. Table Allergan Overview List
12. Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Pfizer Overview List
14. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Shionogi Overview List
16. Table Business Operation of Shionogi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Novo Nordisk Overview List
18. Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Teva Pharmaceutical Overview List
20. Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Bayer. Overview List
22. Table Business Operation of Bayer. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue 2016-2020, by Company, in USD Million
24. Table Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue Share 2016-2020, by Company, in USD Million
25. Table Global Postmenopausal Vaginal Atrophy Treatment Sales Volume 2016-2020, by Company, in Volume
26. Table Global Postmenopausal Vaginal Atrophy Treatment Sales Volume Share 2016-2020, by Company, in Volume
27. Table Regional Demand Comparison List
28. Table Major Application in Different Regions
29. Table Postmenopausal Vaginal Atrophy Treatment Demand Forecast 2021-2026, by Application, in USD Million
30. Table Postmenopausal Vaginal Atrophy Treatment Demand Forecast 2021-2026, by Application, in Volume
31. Table Postmenopausal Vaginal Atrophy Treatment Market Growth 2021-2026, by Application, in Volume
32. Table Postmenopausal Vaginal Atrophy Treatment Market Share in 2026, by Application, in Volume
33. Table Postmenopausal Vaginal Atrophy Treatment Production 2016-2020, by Region, in USD Million
34. Table Postmenopausal Vaginal Atrophy Treatment Production 2016-2020, by Region, in Volume
35. Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2020, by Region, in USD Million
36. Table Global Postmenopausal Vaginal Atrophy Treatment Market Share 2016-2020, by Region, in USD Million
37. Table Global Postmenopausal Vaginal Atrophy Treatment Market 2016-2020, by Region, in Volume
38. Table Global Postmenopausal Vaginal Atrophy Treatment Market Share 2016-2020, by Region, in Volume
39. Table North America Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
40. Table North America Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
41. Table Europe Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
42. Table Europe Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
43. Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
44. Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
45. Table South America Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
46. Table South America Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
47. Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in USD Million
48. Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Size 2016-2020, by Country, in Volume
49. Table Postmenopausal Vaginal Atrophy Treatment Market Forecast 2021-2026, by Region, in USD Million
50. Table Postmenopausal Vaginal Atrophy Treatment Market Forecast 2021-2026, by Region, in Volume
51. Table Price Factors List
LIST OF FIGURES
1. Figure Postmenopausal Vaginal Atrophy Treatment Industry Chain Structure
2. Figure Global Postmenopausal Vaginal Atrophy Treatment Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Postmenopausal Vaginal Atrophy Treatment Market Growth 2016-2020, by Type, in Volume
4. Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Postmenopausal Vaginal Atrophy Treatment Market Concentration, in 2020
7. Figure Europe Postmenopausal Vaginal Atrophy Treatment Market Market Concentration, in 2020
8. Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment MMarket Concentration, in 2020
9. Figure South America Postmenopausal Vaginal Atrophy Treatment Market Concentration, in 2020
10. Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Concentration, in 2020
11. Figure Postmenopausal Vaginal Atrophy Treatment Demand in Topical Estrogen, 2016-2020, in USD Million
12. Figure Postmenopausal Vaginal Atrophy Treatment Demand in Topical Estrogen, 2016-2020, in Volume
13. Figure Postmenopausal Vaginal Atrophy Treatment Demand in Systemic Estrogen, 2016-2020, in USD Million
14. Figure Postmenopausal Vaginal Atrophy Treatment Demand in Systemic Estrogen, 2016-2020, in Volume
15. Figure Postmenopausal Vaginal Atrophy Treatment Demand in Non-hormonal Therapy, 2016-2020, in USD Million
16. Figure Postmenopausal Vaginal Atrophy Treatment Demand in Non-hormonal Therapy, 2016-2020, in Volume
17. Figure Postmenopausal Vaginal Atrophy Treatment Market Growth 2021-2026, by Application, in USD Million
18. Figure Postmenopausal Vaginal Atrophy Treatment Market Share in 2026, by Application, in USD Million
19. Figure North America Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
20. Figure North America Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
21. Figure Europe Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
25. Figure South America Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
26. Figure South America Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview


More Publications